a Positron Emission Tomography (PET) imaging agent for the in vivo diagnosis of breast and prostate cancer
an in vitro diagnostic kit used for detecting shed prostate and bladder cancer cells in voided urine
NuView Life Sciences intends to develop therapeutic applications of the NV-VPAC1 technology.
NuView Life Sciences is a clinical stage oncology company addressing unmet medical needs.
NuView Life Sciences, Inc
1389 Center Drive, Suite 200
Park City, Utah 84098
© 2020 NuView Life Sciences.